Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|January 5, 2021
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort studyKarin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, et al.
The Journal of Rheumatology|July 17, 2019
Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry StudyMarie Skougaard, Tanja Schjødt Jørgensen, Signe Rifbjerg-Madsen, et al.
RMD Open|February 28, 2023
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registersBenedicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, et al.
BMJ Open|April 17, 2016
Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: protocol for a prospective, exploratory cohort studyPil Højgaard, Robin Christensen, Lene Dreyer, et al.
RMD Open|December 23, 2022
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort studyRene Lindholm Cordtz, Johan Askling, Benedicte Delcoigne, et al.
EULAR Rheumatology Open|June 29, 2026
Biological tapering is cost-effective in patients with inflammatory arthritis in the biosimilar era: secondary analyses on the randomised BIODOPT trialLine Uhrenholt, Mads Engell Refstrup Sørensen, Jan Sørensen, et al.
Arthritis Care & Research|July 6, 2018
Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort StudyPil Højgaard, Karen Ellegaard, Sabrina Mai Nielsen, et al.
Arthritis Care & Research|November 25, 2014
Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter studyLouise P Diederichsen, Axel C P Diederichsen, Jane A Simonsen, et al.
Rheumatology International|July 23, 2024
Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trialLine Uhrenholt, Mads E R Sørensen, Karen B Lauridsen, et al.
Arthritis and Rheumatism|December 30, 2009
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registryMerete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp, et al.
Pageof 13